Complementary Alternative Cardiovascular Medicine
Complementary Alternative Cardiovascular Medicine
Complementary Alternative Cardiovascular Medicine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Chapter 7 / Nutrachemicals and CVD 119<br />
45. Brevetti G, Perna S, Sabba C, Martone VD, Condorelli M. Propionyl-L-carnitine in<br />
intermittent claudication: double-blind, placebo-controlled, dose titration,<br />
multicenter study. J Am Coll Cardiol 1995;26:1411–1416.<br />
46. Palazzuli V, Mondillo S, Faglia S, D’Aprile N, Camporeale A, Gennari C. The<br />
evaluation of antiarrhythmic activity of L-carnitine and propafenone in ischemic<br />
cardiomyopathy. Clinica Therapeutica 1993;142:155–159.<br />
47. Gavish D, Breslow JL. Lipoprotein(a) reduction by N-acetylcysteine. Lancet<br />
1991;337:203–204.<br />
48. Wiklund O, Fager G, Andersson A, Lundstam U, Masson P, Hultberg B. Nacetylcysteine<br />
treatment lowers plasma homocysteine but not serum lipoprotein(a)<br />
levels. Atherosclerosis 1996;119:99–106.<br />
49. Bostom AG, Shemin D, Yoburn D, Fisher DH, Nadeau MR, Selhub J. Lack of effect<br />
of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma<br />
homocysteine in hemodialysis patients. Atherosclerosis 1996;120:241–244.<br />
50. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of cardiovascular<br />
effect of nitroglycerine by N-acetylcysteine. Circulation 1983;68:1247–1253.<br />
51. Ardissino D, Merlini PA, Savonitto S, et al. Effect of transdermal nitroglycerine or<br />
N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. J<br />
Am Coll Cardiol 1997;29:941–947.<br />
52. Tepel M, Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of<br />
radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.<br />
N Engl J Med 2000;343:180–184.<br />
53. Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic heart<br />
failure increases skeletal muscle creatine phosphate and muscle performance.<br />
Cardiovasc Res 1995;30:413–418.<br />
54. Andrews R, Greenhaff P, Curtis S, Perry A, Cowley AJ. The effect of dietary<br />
creatine supplementation on skeletal muscle metabolism in congestive heart failure.<br />
Eur Heart J 1998;19:617-622.<br />
55. Stamler JS, Slivka A. Biological chemistry of thiols in vasculature and in vascularrelated<br />
diseases. Nutr Rev 1996;54:1–30.<br />
56. Morrison JA, Jacobsen DW, Sprecher DL, Robinson K, Khoury P, Daniels SR.<br />
Serum glutathione in adolescent males predicts parental coronary heart disease.<br />
Circulation 1999;100(22):2244–2247.<br />
57. Prasad A, Andrews NP, Padder FA, Husain M, Quyyumi AA. Glutathione reverses<br />
endothelial dysfunction and improves nitric oxide bioavailability. J Am Coll Cardiol<br />
1999;34:507–514.<br />
58. Langford EJ, Brown AS, Wainwright RJ, et al. Inhibition of platelet activity by Snitrosoglutathione<br />
during coronary angioplasty. Lancet 1994;344:1458–1460.<br />
59. Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial<br />
infarction and unstable angina is inhibited by nitric oxide donors. Arterioscl Thromb<br />
Vasc Biol 1996;16:51–55.<br />
60. Burke MP, Opeskin K. Fulminant heart failure due to selenium deficiency cardiomyopathy<br />
(Keshan disease). Med Sci Law 2002;42:10–13.<br />
61. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk<br />
1996;3:42–47.<br />
62. Kok FJ, Hofman A, Witteman JC, et al.Decreased selenium levels in acute myocardial<br />
infarction. JAMA 1989;263:949–950.<br />
63. Salvini S, Hennekens CH, Morris S, Willett WC, Stampfer MJ. Plasma levels of the<br />
antioxidant selenium and risk of myocardial infarction among U.S. Physicians. Am<br />
J Cardiol 1995;76:1218–1221.
Change language